Find comprehensive information on pituitary macroadenoma diagnosis, including clinical documentation requirements, ICD-10 codes (D35.2), SNOMED CT concepts, and healthcare guidelines. Learn about pituitary adenoma symptoms, treatment options, and the role of medical coding in accurate billing and reimbursement. Explore resources for healthcare professionals, including diagnostic criteria and best practices for documenting pituitary macroadenomas in patient records. This resource helps ensure accurate and efficient clinical documentation and coding for pituitary macroadenoma cases.
Also known as
Benign neoplasm of pituitary gland
This code specifies a non-cancerous tumor of the pituitary gland.
Acromegaly and gigantism
These conditions are often caused by pituitary macroadenomas overproducing growth hormone.
Hyperprolactinemia
Macroadenomas can cause overproduction of prolactin, leading to this condition.
Neoplasm of uncertain behavior of pituitary
Used when the behavior of the pituitary tumor is not clearly benign or malignant.
Macroadenomas are >10mm. Insufficient documentation of size may lead to incorrect coding or downcoding to microadenoma.
Coding requires specifying functional status (e.g., secreting vs. non-secreting) for accurate code assignment and reimbursement.
Macroadenomas can cause complications like visual field defects or hypopituitarism. These must be coded separately.
Patient presents with concerning symptoms suggestive of pituitary macroadenoma. Clinical presentation includes [specific symptoms e.g., headaches, visual field deficits such as bitemporal hemianopsia, hypopituitarism manifestations including hypothyroidism, adrenal insufficiency, hypogonadism, galactorrhea, amenorrhea, infertility]. Patient reports [onset, duration, and character of symptoms]. Physical examination reveals [relevant findings e.g., visual field defects assessed by confrontation, cranial nerve abnormalities]. Biochemical evaluation demonstrates [hormonal levels e.g., prolactin, IGF-1, cortisol, TSH, free T4, LH, FSH, testosterone or estradiol]. MRI of the sella turcica confirms the presence of a macroadenoma measuring [size] mm in diameter, with [description of location and extension e.g., suprasellar extension, compression of the optic chiasm]. Differential diagnosis includes other sellar masses such as craniopharyngioma, meningioma, and Rathke cleft cyst. The diagnosis of pituitary macroadenoma is established based on the correlation of clinical manifestations, hormonal profile, and imaging findings. Treatment plan includes [options discussed e.g., transsphenoidal surgery, medical therapy with dopamine agonists such as cabergoline or bromocriptine, radiation therapy, or a combination thereof]. Risks and benefits of each treatment modality were discussed with the patient. Patient understands the treatment plan and agrees to proceed with [chosen treatment]. Follow-up is scheduled to monitor treatment response and manage potential complications such as hypopituitarism, cerebrospinal fluid leak, and visual deficits. ICD-10 code D35.2 is assigned.